AAAAAA

   
Results: 1-16 |
Results: 16
PERFORMANCE OF HUMAN MASS-BALANCE STUDIES WITH STABLE ISOTOPE-LABELEDDRUG AND CONTINUOUS-FLOW ISOTOPE RATIO MASS-SPECTROMETRY - A PROGRESSREPORT
Authors: BROWNE TR SZABO GK AJAMI A BROWNE DG
Citation: Tr. Browne et al., PERFORMANCE OF HUMAN MASS-BALANCE STUDIES WITH STABLE ISOTOPE-LABELEDDRUG AND CONTINUOUS-FLOW ISOTOPE RATIO MASS-SPECTROMETRY - A PROGRESSREPORT, Journal of clinical pharmacology, 38(4), 1998, pp. 309-314
STABLE-ISOTOPE TECHNIQUES IN EARLY DRUG DEVELOPMENT - AN ECONOMIC-EVALUATION
Authors: BROWNE TR
Citation: Tr. Browne, STABLE-ISOTOPE TECHNIQUES IN EARLY DRUG DEVELOPMENT - AN ECONOMIC-EVALUATION, Journal of clinical pharmacology, 38(3), 1998, pp. 213-220
PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS
Authors: BROWNE TR
Citation: Tr. Browne, PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS, Neurology, 51(5), 1998, pp. 2-7
INTRAVENOUS PHENYTOIN - CHEAP BUT NOT NECESSARILY A BARGAIN
Authors: BROWNE TR
Citation: Tr. Browne, INTRAVENOUS PHENYTOIN - CHEAP BUT NOT NECESSARILY A BARGAIN, Neurology, 51(4), 1998, pp. 942-943
CENTRAL LEVODOPA METABOLISM IN PARKINSONS-DISEASE AFTER ADMINISTRATION OF STABLE ISOTOPE-LABELED LEVODOPA
Authors: DURSO R EVANS JE JOSEPHS E SZABO GK EVANS BA HANDLER JS JENNINGS D BROWNE TR
Citation: R. Durso et al., CENTRAL LEVODOPA METABOLISM IN PARKINSONS-DISEASE AFTER ADMINISTRATION OF STABLE ISOTOPE-LABELED LEVODOPA, Annals of neurology, 42(3), 1997, pp. 300-304
FOSPHENYTOIN (CEREBYX)
Authors: BROWNE TR
Citation: Tr. Browne, FOSPHENYTOIN (CEREBYX), Clinical neuropharmacology, 20(1), 1997, pp. 1-12
PHENYTOIN METABOLISM - PHARMACOGENETIC DIFFERENCES AND LACK OF INHIBITION BY CARBAMAZEPINE, CARBAMAZEPINE EPOXIDE, AND CARBAMAZEPINE DIOL
Authors: LEDUC BW SZABO GK BROWNE TR
Citation: Bw. Leduc et al., PHENYTOIN METABOLISM - PHARMACOGENETIC DIFFERENCES AND LACK OF INHIBITION BY CARBAMAZEPINE, CARBAMAZEPINE EPOXIDE, AND CARBAMAZEPINE DIOL, Neurology, 48(3), 1997, pp. 2056-2056
STUDY OF DRUG-INTERACTIONS WITH PHENYTOIN USING A STABLE-ISOTOPE TRACER METHOD NOT REQUIRING MASS-SPECTROMETRY
Authors: BROWNE TR SZABO GK JOSEPHS E KRES J DINGRA U
Citation: Tr. Browne et al., STUDY OF DRUG-INTERACTIONS WITH PHENYTOIN USING A STABLE-ISOTOPE TRACER METHOD NOT REQUIRING MASS-SPECTROMETRY, Neurology, 48(3), 1997, pp. 2060-2060
SAFETY AND EFFICACY OF DIVALPROEX SODIUM MONOTHERAPY IN PARTIAL EPILEPSY - A DOUBLE-BLIND, CONCENTRATION-RESPONSE DESIGN CLINICAL-TRIAL
Authors: BEYDOUN A SACKELLARES JC SHU V BORNHOFEN JH BORRESON T BROWNE TR CASCINO GD DEATON R DEVINSKY O DRAKE ME FROMM GH GALLAGHER BB GRIGGS WL HIRSCHORN KA HOMAN RW KAPLAN L KRAUSS GL KUZNIECKY RI CHI WL MAMDANI MB MCPHERSON SL MIRZA WU MORRIS GL MURRAY KR PAKAINIS A PENOVICH P RAMSAY RE RASK C RISINGER MW ROGIN JB ROOS K TENNISON M THADANI V VALERIANO JP WEISBERG LA
Citation: A. Beydoun et al., SAFETY AND EFFICACY OF DIVALPROEX SODIUM MONOTHERAPY IN PARTIAL EPILEPSY - A DOUBLE-BLIND, CONCENTRATION-RESPONSE DESIGN CLINICAL-TRIAL, Neurology, 48(1), 1997, pp. 182-188
PROGNOSIS FOR TOTAL CONTROL OF COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES
Authors: MATTSON RH CRAMER JA COLLINS JF BROWNE TR CRILL WE HOMAN RW CARTER GS MAYERSDORF A DAVENPORT J LUBOZYNSKI MF WILLIAMSON PD EBERSOLE JS SCHEYER RD MCCUTCHEN CB MAMDANI MB RAMSAY RE ROWAN AJ SALINSKY M MCNAMARA JO SHIN C SMITH DB TREIMAN DM DELGADOESCUETA AV ROSENTHAL NP WARNER JJ WILDER BJ
Citation: Rh. Mattson et al., PROGNOSIS FOR TOTAL CONTROL OF COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES, Neurology, 47(1), 1996, pp. 68-76
PHARMACOLOGY AND PHARMACOKINETICS OF FOSPHENYTOIN
Authors: BROWNE TR KUGLER AR ELDON MA
Citation: Tr. Browne et al., PHARMACOLOGY AND PHARMACOKINETICS OF FOSPHENYTOIN, Neurology, 46(6), 1996, pp. 3-7
DOUBLE-BLIND CROSSOVER COMPARISON OF TEGRETOL-XR AND TEGRETOL IN PATIENTS WITH EPILEPSY
Authors: BROWNE TR MORRIS HH BOURGEOIS B ERENBERG G VANNESS PC WYLLIE E ROTHNER AD CRUSE R COHEN BH RAMSAY RE KATZ D CURLESS R GUTERMAN A CURTIS V SLATER J GROSZ R AVERY A WILDER BJ UTHMAN BM FISHER RS LESSER RP
Citation: Tr. Browne et al., DOUBLE-BLIND CROSSOVER COMPARISON OF TEGRETOL-XR AND TEGRETOL IN PATIENTS WITH EPILEPSY, Neurology, 45(9), 1995, pp. 1703-1707
VIGABATRIN (SABRIL)
Authors: KURLAND AH BROWNE TR
Citation: Ah. Kurland et Tr. Browne, VIGABATRIN (SABRIL), Clinical neuropharmacology, 17(6), 1994, pp. 560-568
DETERMINATION OF PHARMACOKINETIC DRUG-INTERACTIONS WITH CARBAMAZEPINEAND PHENYTOIN USING STABLE-ISOTOPE LABELING AND SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ULTRAVIOLET DETECTION TECHNIQUE
Authors: BROWNE TR SZABO GK DAVOUDI H JOSEPHS EG
Citation: Tr. Browne et al., DETERMINATION OF PHARMACOKINETIC DRUG-INTERACTIONS WITH CARBAMAZEPINEAND PHENYTOIN USING STABLE-ISOTOPE LABELING AND SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ULTRAVIOLET DETECTION TECHNIQUE, Neurology, 44(12), 1994, pp. 2410-2411
CLINICAL-TRIALS PERFORMED FOR THE NEW DRUG APPROVAL PROCESS IN THE UNITED-STATES - STANDARD METHODS AND ALTERNATIVE METHODS
Authors: BROWNE TR
Citation: Tr. Browne, CLINICAL-TRIALS PERFORMED FOR THE NEW DRUG APPROVAL PROCESS IN THE UNITED-STATES - STANDARD METHODS AND ALTERNATIVE METHODS, Epilepsy research, 1993, pp. 31-44
LONG-TERM EFFICACY AND TOXICITY OF GABAPENTIN
Authors: BROWNE TR
Citation: Tr. Browne, LONG-TERM EFFICACY AND TOXICITY OF GABAPENTIN, Neurology, 43(4), 1993, pp. 307-307
Risultati: 1-16 |